Pineton de Chambrun GP - Search Results

1

The role of anti(myco)bacterial interventions in the management of IBD: is there evidence at all?

Pineton de Chambrun GP, Torres J, Darfeuille-Michaud A, Colombel JF. Pineton de Chambrun GP, et al. Dig Dis. 2012;30(4):358-67. doi: 10.1159/000338126. Epub 2012 Jul 12. Dig Dis. 2012. PMID: 22796797 Review.

2

Pathogenic agents in inflammatory bowel diseases.

Pineton de Chambrun G, Colombel JF, Poulain D, Darfeuille-Michaud A. Pineton de Chambrun G, et al. Curr Opin Gastroenterol. 2008 Jul;24(4):440-7. doi: 10.1097/MOG.0b013e3283023be5. Curr Opin Gastroenterol. 2008. PMID: 18622157 Review.

3

Clinical implications of mucosal healing for the management of IBD.

Pineton de Chambrun G, Peyrin-Biroulet L, Lémann M, Colombel JF. Pineton de Chambrun G, et al. Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):15-29. doi: 10.1038/nrgastro.2009.203. Epub 2009 Dec 1. Nat Rev Gastroenterol Hepatol. 2010. PMID: 19949430 Review.

4

Review article: colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease.

Torres J, Pineton de Chambrun G, Itzkowitz S, Sachar DB, Colombel JF. Torres J, et al. Aliment Pharmacol Ther. 2011 Sep;34(5):497-508. doi: 10.1111/j.1365-2036.2011.04753.x. Epub 2011 Jun 22. Aliment Pharmacol Ther. 2011. PMID: 21692821 Free article. Review.

5

Natural history of eosinophilic gastroenteritis.

Pineton de Chambrun G, Gonzalez F, Canva JY, Gonzalez S, Houssin L, Desreumaux P, Cortot A, Colombel JF. Pineton de Chambrun G, et al. Clin Gastroenterol Hepatol. 2011 Nov;9(11):950-956.e1. doi: 10.1016/j.cgh.2011.07.017. Epub 2011 Jul 30. Clin Gastroenterol Hepatol. 2011. PMID: 21806952

6

Stevens-Johnson syndrome with sulfasalazine treatment: report of two cases.

Tremblay L, Pineton de Chambrun G, De Vroey B, Lavogiez C, Delaporte E, Colombel JF, Cortot A. Tremblay L, et al. J Crohns Colitis. 2011 Oct;5(5):457-60. doi: 10.1016/j.crohns.2011.03.014. Epub 2011 May 6. J Crohns Colitis. 2011. PMID: 21939920

7

Trough levels and antibodies to infliximab may not predict response to intensification of infliximab therapy in patients with inflammatory bowel disease.

Pariente B, Pineton de Chambrun G, Krzysiek R, Desroches M, Louis G, De Cassan C, Baudry C, Gornet JM, Desreumaux P, Emilie D, Colombel JF, Allez M. Pariente B, et al. Inflamm Bowel Dis. 2012 Jul;18(7):1199-206. doi: 10.1002/ibd.21839. Epub 2011 Aug 29. Inflamm Bowel Dis. 2012. PMID: 22127789

8

IBD in 2011: Advances in IBD management--towards a tailored approach.

Pineton de Chambrun GP, Sandborn WJ. Pineton de Chambrun GP, et al. Nat Rev Gastroenterol Hepatol. 2012 Jan 10;9(2):70-2. doi: 10.1038/nrgastro.2011.248. Nat Rev Gastroenterol Hepatol. 2012. PMID: 22230905 Review. No abstract available.

9

Farnesoid X receptor expression is decreased in colonic mucosa of patients with primary sclerosing cholangitis and colitis-associated neoplasia.

Torres J, Bao X, Iuga AC, Chen A, Harpaz N, Ullman T, Cohen BL, Pineton de Chambrun G, Asciutti S, Odin JA, Sachar DB, Gaskins HR, Setchell K, Colombel JF, Itzkowitz SH. Torres J, et al. Inflamm Bowel Dis. 2013 Feb;19(2):275-82. doi: 10.1097/MIB.0b013e318286ff2e. Inflamm Bowel Dis. 2013. PMID: 23348121

10

Vaccination and Risk for Developing Inflammatory Bowel Disease: A Meta-Analysis of Case-Control and Cohort Studies.

Pineton de Chambrun G, Dauchet L, Gower-Rousseau C, Cortot A, Colombel JF, Peyrin-Biroulet L. Pineton de Chambrun G, et al. Clin Gastroenterol Hepatol. 2015 Aug;13(8):1405-15.e1; quiz e130. doi: 10.1016/j.cgh.2015.04.179. Epub 2015 May 5. Clin Gastroenterol Hepatol. 2015. PMID: 25956840 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

48 results

Search Page